United Therapeutics (UTHR)

P/S ratio as of October 2026 (TTM): 8.17

According to United Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.03. At the end of 2026 the company had a P/S ratio of 7.30.

P/S ratio history for United Therapeutics from 2001 to 2026

PS ratio at the end of each year

Year	P/S ratio	Change
2026	7.30	3.45%
2025	7.06	26.38%
2024	5.58	25.8%
2023	4.44	-32.17%
2022	6.55	13.37%
2021	5.77	26.96%
2020	4.55	70.46%
2019	2.67	-8.51%
2018	2.92	-21.3%
2017	3.71	-2.62%
2016	3.81	-22.17%
2015	4.89	3.28%
2014	4.73	-7.2%
2013	5.10	74.38%
2012	2.93	-21.12%
2011	3.71	-38.98%
2010	6.08	-21.25%
2009	7.72	49.54%
2008	5.16	-49.88%
2007	10.3	40.8%
2006	7.31	-47.4%
2005	13.9	1.05%
2004	13.8	50.09%
2003	9.17	-20.97%
2002	11.6	-68.42%
2001	36.7

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Pfizer PFE	2.73	-66.62%	🇺🇸 USA
Eli Lilly LLY	15.9	94.08%	🇺🇸 USA
Baxter BAX	1.02	-87.49%	🇺🇸 USA
Gilead Sciences GILD	6.97	-14.65%	🇺🇸 USA
Cardinal Health CAH	0.2289	-97.20%	🇺🇸 USA
GSK plc GSK	2.24	-72.60%	🇬🇧 UK
Cytokinetics CYTK	130	1,485.70%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	2.79	-65.81%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for United Therapeutics (UTHR)

P/S ratio as of October 2026 (TTM): 8.17